Home » Topics » Regulatory

Regulatory
RSS

Glaxo Wellcome launches Flovent for pediatric asthma in U.S.

April 28, 1998

Glaxo Wellcome seeks approval for combination asthma product

April 28, 1998

New antiglaucoma agent approved in U.S.

April 24, 1998

Abbott's vitamin D analogue approved for secondary hyperparathyroidism

April 24, 1998

Searle introduces new formulation of verapamil hydrochloride in Canada

April 23, 1998

First marketing approval for Novartis transplant drug

April 22, 1998

FDA clears new indication for Prevacid

April 17, 1998

Cosopt receives marketing approval from FDA

April 16, 1998

Antiviral drugs advisory committee will discuss Intron A/Rebetol NDA

April 15, 1998

FDA approves fifth indication for Neupogen

April 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.